Taking Wegovy and Sertraline Together: What You Need to Know

You're already on sertraline and someone has mentioned Wegovy, here's what that actually means

Picture the scenario: you've been managing depression or anxiety with sertraline for a while, your weight has become a health concern, and a clinician has raised Wegovy as an option. Your first question is a sensible one: will these two medicines interfere with each other?

The short answer is that sertraline is not listed as a contraindication or a specific named interaction in the Wegovy prescribing information. The NHS patient-level guidance on semaglutide acknowledges that the medicine slows how quickly the stomach empties food into the small intestine. Because many oral medicines are absorbed partly in the upper gut, that delay can, in theory, alter their absorption profile. For sertraline (which is absorbed gradually in any case) this effect is unlikely to be dramatic, but it is a reason your prescriber will want to know you're taking it.

It is also worth knowing that significant weight loss can change the way your body processes some medicines. Body composition, plasma volume and liver enzyme activity all shift as weight reduces, and for a medicine like sertraline (where the therapeutic window and individual response already vary considerably) your GP or psychiatrist may want to monitor how you're feeling more closely than usual once Wegovy is started. None of this makes the combination off-limits; it makes it a clinical conversation rather than a self-service decision. You can read more about how semaglutide works at a pharmacological level on our semaglutide overview.

What the Wegovy SmPC and NHS guidance actually say about medicine interactions

The Summary of Product Characteristics for Wegovy (the formal prescribing document) addresses drug interactions in its own section. It notes that semaglutide's gastric-emptying effect has the potential to influence the absorption of concomitant oral medicines, and it advises caution. In the clinical studies conducted during development, co-administration with a range of medicines was examined; no interaction that required dose adjustment was identified for the drugs tested. Sertraline was not among the specifically studied agents, which is a common position for SSRIs in trials of this type.

What this means practically: there is no red-flag warning that says sertraline and semaglutide cannot be used together. What exists is a general caution about oral medicines whose absorption could theoretically be time-sensitive. Sertraline is taken once daily and its effects build over weeks, so a modest delay in any single dose's absorption is unlikely to produce a detectable clinical change in most people. That said, "unlikely" and "ruled out" are not the same thing.

The NHS medicines page for semaglutide advises telling your prescriber about all medicines you take, specifically because of the gastric-emptying effect. That guidance is the practical upshot of everything above. A fuller technical reference is available in the BNF's semaglutide monograph if your clinician wants the professional-level detail.

Mood, weight loss and why monitoring is part of the deal

There's another layer here that goes beyond pharmacokinetics. Starting a GLP-1 medicine like Wegovy can bring significant changes, in appetite, energy, and over time, in body weight. Weight loss is associated with improvements in mood for many people, but the journey isn't linear. Nausea, fatigue and reduced appetite in the early weeks can feel dispiriting, particularly for someone who already manages their mental health. This isn't a reason to avoid treatment; it's a reason to stay in contact with your healthcare team.

If your mood changes after starting Wegovy (better or worse) that's worth mentioning to whoever manages your sertraline, and our Wegovy and sertraline page goes into more detail about what those changes can look like and why they matter. The aim isn't to alarm you; it's to make sure any adjustment to your antidepressant dose happens intentionally rather than by accident. Clinical guidance from NHS England on weight-management injections includes a general recommendation to review co-prescribed medicines as treatment progresses.

If you're considering Wegovy alongside an existing mental health medicine, our prescribers at nume take a detailed history at consultation (including your current prescriptions) before any decision is made. The Wegovy treatment page gives an overview of the assessment process, and if you have questions about costs, the Wegovy price page covers what's included. Information on other combination questions is on our semaglutide and sertraline page.

When to talk to your prescriber before starting or changing anything

You should not start Wegovy, stop sertraline, or change the dose of either without speaking to a prescriber first. That applies whether the Wegovy would be prescribed privately or through the NHS. The clinical assessment for Wegovy includes a review of your current medicines precisely because of scenarios like this one.

If you experience new or worsening symptoms after starting Wegovy (mood changes, unusual anxiety, gastrointestinal symptoms that persist beyond the first two weeks, or anything that feels out of the ordinary) contact your prescriber or GP, and if you have also been wondering whether you can take Ozempic and semaglutide together, that page addresses a related question worth reading before your consultation. Any suspected side effect from either medicine can be reported through the MHRA's Yellow Card scheme, which collects post-marketing safety data and is open to patients as well as clinicians.

Both Wegovy and sertraline are prescription-only medicines for good reason. The right combination, dose and monitoring plan is one a clinician builds around your specific history. Our consultation page is the place to start if you want a prescriber to review the full picture. You can also read how nume handles combinations and co-prescribing questions on our FAQs page.